Table 3. Measures of 24 to 48 hour blood values by Intention-to-Treat and Sensitivity Analyses (Actual treatment).
Two Day Values | Intention-to-treat | Actual Treatment | ||||
---|---|---|---|---|---|---|
DCC (n=37) | ICC (n=36) | P value | DCC (n=37) | ICC (n=36) | P value | |
Hemoglobin (g/dL), (capillary) | 19.4 ± 2 (16.3–25.0) | 17.8 ± 2 (14.5–22.5) | 0.002 | 19.5 ± 2.1 (16.3–25) | 17.7 ± 1.8 (14.5–22.2) | 0.002 |
Hematocrit (%), (capillary) | 58 ± 6.2 (50.3–73.7) | 53 ± 5.4 (42.4–63.8) | 0.001 | 58.4 ± 6.2 (50.9–73.7) | 52.5 ± 5.2 (42.4–64.4) | 0.001 |
Peak total serum bilirubin (TSB) level, (mg/dL)* | 9 ± 3 (1.8–15.3) | 8.5 ± 3 (1.7–13.5) | 0.50 | 8.5 ± 3 (1.8–14.9) | 9.0 ± 3.2 (1.7–15.3) | 0.45 |
Bilirubin Nomogram High risk zone (≥95%) (bilitool.org) | 2 (5) | 2 (6) | 0.95 | 1 (3) | 3 (9) | 0.28 |
Phototherapy (initial hospital stay) | 4 (11) | 0 (0) | 0.04 | 2 (5) | 2 (6) | 0.98 |
Symptomatic Polycythemia | 0 | 0 | -- | 0 | 0 | -- |
Capillary Hematocrit > 65% | 6 (16) | 0 (0) | 0.01 | 6 (16) | 0 (0) | 0.01 |
Capillary Hematocrit >70% | 1 (3) | 0 (0) | 0.33 | 1 (3) | 0 (0) | 0.32 |
Capillary Hematocrit < 47% | 0 (0) | 5 (14) | 0.02 | 0 (0) | 5 (14) | 0.02 |
N (%) or mean ± SD (range);
TSB collection time ranged from 31 to 56 hours of age